Guest guest Posted June 7, 2006 Report Share Posted June 7, 2006 Independent Oncology Conference Coverage from Atlanta <http://www.ccoemail.com/flotation/f1zgwy8C0bzndCmq3Cqeeyt7Cqz6/b.gif> <http://images.imedoptions.com/img.asp?img=cco/CCO_Header_HO.gif> *CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs. Latest <http://www.ccoemail.com/ccoemail/f1zgwy8C0bzndCmq3Cqeeyt7Cqz6/2/clinica loptions.com/Oncology/Conference%20Coverage/Clin%20Oncology%20June%20200 6.aspx> Data in Clinical Oncology CCO Independent Conference Coverage of the 2006 Annual Meeting of the American Society of Clinical Oncology,* June 2-6, 2006 | Atlanta, Georgia <http://images.imedoptions.com/img.asp?img=cco_bar/bar_onc_news_headline s.jpg> * <http://www.ccoemail.com/ccoemail/f1zgwy8C0bzndCmq3Cqeeyt7Cqz6/2/clinica loptions.com/Oncology/Conference%20Coverage/Clin%20Oncology%20June%20200 6/News/News_0001.aspx> Addition of thalidomide to standard frontline MP therapy improves survival in elderly patients with multiple myeloma * <http://www.ccoemail.com/ccoemail/f1zgwy8C0bzndCmq3Cqeeyt7Cqz6/2/clinica loptions.com/Oncology/Conference%20Coverage/Clin%20Oncology%20June%20200 6/News/News_0002.aspx> Mutations of KIT tyrosine kinase receptor gene predict for higher risk of relapse in adult patients with acute myeloid leukemia * <http://www.ccoemail.com/ccoemail/f1zgwy8C0bzndCmq3Cqeeyt7Cqz6/2/clinica loptions.com/Oncology/Conference%20Coverage/Clin%20Oncology%20June%20200 6/News/News_9513.aspx> Sunitinib prolongs time to progression in patients with GIST after imatinib failure * <http://www.ccoemail.com/ccoemail/f1zgwy8C0bzndCmq3Cqeeyt7Cqz6/2/clinica loptions.com/Oncology/Conference%20Coverage/Clin%20Oncology%20June%20200 6/News/News_2501.aspx> Therapeutic dual viral vector vaccine plus GM-CSF does not improve progression-free survival in phase II randomized trial in hormone-refractory prostate cancer patients * <http://www.ccoemail.com/ccoemail/f1zgwy8C0bzndCmq3Cqeeyt7Cqz6/2/clinica loptions.com/Oncology/Conference%20Coverage/Clin%20Oncology%20June%20200 6/News/News_0000.aspx> Adding lapatinib to capecitabine prolongs time to progression in women with advanced or metastatic breast cancer * <http://www.ccoemail.com/ccoemail/f1zgwy8C0bzndCmq3Cqeeyt7Cqz6/2/clinica loptions.com/Oncology/Conference%20Coverage/Clin%20Oncology%20June%20200 6/News/News_4502.aspx> Lapatinib may prolong overall survival in patients with advanced renal cell carcinoma overexpressing ErbB1 These headlines are located online at: <http://www.ccoemail.com/ccoemail/f1zgwy8C0bzndCmq3Cqeeyt7Cqz6/2/clinica loptions.com/Oncology/Conference%20Coverage/Clin%20Oncology%20June%20200 6.aspx> http://clinicaloptions.com/Oncology/Conference%20Coverage/Clin%20Oncolog y%20June%202006.aspx <http://images.imedoptions.com/img.asp?img=cco_bar/bar_onc_capsule_summa ries.gif> Gastrointestinal Cancer * 21-Gene <http://www.ccoemail.com/ccoemail/f1zgwy8C0bzndCmq3Cqeeyt7Cqz6/2/clinica loptions.com/Oncology/Conference%20Coverage/Clin%20Oncology%20June%20200 6/Capsules/3518.aspx?Track=Gastrointestinal> RT-PCR Assay May Predict Recurrence in Colon Cancer * Negative <http://www.ccoemail.com/ccoemail/f1zgwy8C0bzndCmq3Cqeeyt7Cqz6/2/clinica loptions.com/Oncology/Conference%20Coverage/Clin%20Oncology%20June%20200 6/Capsules/4024.aspx?Track=Gastrointestinal> Endoscopy After Chemoradiation for Esophageal Cancer Does Not Predict Pathologic Complete Response These Capsule Summaries are located online at: <http://www.ccoemail.com/ccoemail/f1zgwy8C0bzndCmq3Cqeeyt7Cqz6/2/clinica loptions.com/Oncology/Conference%20Coverage/Clin%20Oncology%20June%20200 6/Tracks/Gastrointestinal.aspx> http://clinicaloptions.com/Oncology/Conference%20Coverage/Clin%20Oncolog y%20June%202006/Tracks/Gastrointestinal.aspx Coming Soon: CME-Certified Expert Analyses <http://images.imedoptions.com/img.asp?img=/logo/pimlogo.jpg> <http://images.imedoptions.com/img.asp?img=/cco/CCO_onc_logo.jpg> This activity is jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC. Supported by educational grants from: Bristol-Myers Squibb Company, Roche Pharmaceuticals, and sanofi-aventis U.S. <http://images.imedoptions.com/img.asp?img=/logo/BMS_248x34.gif> <http://clinicaloptions.com/x/images/email/roche_logo.gif> <http://images.imedoptions.com/img.asp?img=/logo/sanofi_aventis_150.gif> <http://www.ccoemail.com/ccoemail/f1zgwy8C0bzndCmq3Cqeeyt7Cqz6/2/clinica loptions.com/Oncology/Resources/Bookstore.aspx> Unsubscribe <http://www.ccoemail.com/enlisted/0/f1zgwy8C0bzndCmq3Cqeeyt7Cqz6> | Not <http://www.ccoemail.com/ccoemail/f1zgwy8C0bzndCmq3Cqeeyt7Cqz6/2/clinica loptions.com/Oncology/Registration.aspx> a member yet? Click here | RSS <http://www.ccoemail.com/ccoemail/f1zgwy8C0bzndCmq3Cqeeyt7Cqz6/2/corp.cl inicaloptions.com/rss.aspx> | Hematology/Oncology <http://www.ccoemail.com/ccoemail/f1zgwy8C0bzndCmq3Cqeeyt7Cqz6/2/corp.cl inicaloptions.com/podcasts.aspx> Podcasts | Bookstore <http://www.ccoemail.com/ccoemail/f1zgwy8C0bzndCmq3Cqeeyt7Cqz6/2/clinica loptions.com/Oncology/Resources/Bookstore.aspx> Copyright 2006 Clinical Care Options, LLC. All rights reserved. 1894 Preston White Drive, Suite 110, Reston, VA, 20191-5433 Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.